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1. INTRODUCTION 
Vasoactive intestinal polypeptide (VIP) has been 
shown to exert a hyperglycemic effect in vivo and 
to induce glucogenolysis in rabbit liver slices [l] 
but the biochemical evidence supporting an effect 
of VIP on glucose metabolism in liver cells is 
scarce [2-31 except for a recently described effect 
[4]. This effect is thought to be cyclic adenosine 
monophosphate (CAMP)-dependent since numer- 
ous studies have shown that VIP can stimulate rat 
liver adenylate cyclase through the interaction with 
a specific membrane receptor [5-81. VIP seems to 
share this membrane binding site with secretin but 
not with glucagon [6] or gastric inhibitory polypep- 
tide (GIP) 131. Although the VIP effect on mem- 
brane adenylate cyclase was clearly documented, 
the action of VIP on CAMP levels in isolated liver 
cells is still unclear [4,8]. The aim of this study was 
to systematically investigate the actions and mech- 
anism of action of VIP, secretin and GIP, three 
glucagon-related polypeptides [9], on glucose and 
lactate metabolism in isolated rat liver cells and to 
compare them to the known, CAMP-mediated, 
effects of glucagon. 
2. MATERIALS AND METHODS 
Porcine VIP and secretin were obtained from 
Professor V. Mutt (Karolinska Institut, Stockholm) 
Abbreviations: VIP, Vasoactive intestinal polypeptide; 
GIP, gastric inhibitory polypeptide; CAMP, 3’,5’-cyclic 
adenosine monophosphate 
Portions of this work have been presented in abstract 
form at the Special FEBS Meeting, Athens, April 1982 
and porcine GIP from Professor J.C. Brown (Van- 
couver). Glucagon, bacitracin, bovine serum al-. 
bumin (fraction V), histone 2b, and protein kinase 
were from Sigma, other enzymes and coenzymes 
from Boehringer, Mannheim. [$*P]adenosine tri- 
phosphate and cyclic [3H]AMP were obtained 
from Amersham. 
Isolated liver cells were prepared from adult 
male rat (180-250 g) with the method of Berry 
and Friend [lo] as described in [ 111. One ml liver 
cells (8-15 mg/ml wet weight, 120 000 cells/mg 
wet weight) were distributed in 20 ml cylindrical 
tubes, continuously shaken and gassed (02 958, 
C@ 5%) and incubated with or without hormone 
in a Krebs-Ringer bicarbonate buffer containing 
albumin 1% and bacitracin 0.1% (w/v). Metab- 
olites were measured according to enzymatic pro- 
cedures in [12]. Pyruvate kinase was assayed spec- 
trophotometrically with the method of Llorente 
[ 131 as described in [ 1 l] in 60% ammonium sulfate 
cell extract prepared by the method in [ 141. CAMP- 
dependent protein kinase activity was measured in 
a 10 000 x g supematant cell extract after homo- 
genizing the liver cells as described in [ 151. The 
assay was performed as described in [ 161 using his- 
tone 2b as substrate. The transfer of [$*P]phos- 
phate from adenosine triphosphate (spec. act. 30- 
40 cpm/pmol) on histone was measured during an 
incubation of 6 min at 30°C with or without 5 PM 
CAMP. One unit of activity is the amount of en- 
zyme which catalyzes the transfer of 1 pmol of 
phosphate on histone per min at 30°C. The protein 
kinase activity ratio was calculated as activity 
minus CAMP/activity plus CAMP [15]. Protein 
concentration was measured with the method of 
Lowry [ 171 using bovine serum albumin as stan- 
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dard. CAMP was determinated by the protein 
kinase binding assay as described in [18]. Aliquots 
(1 ml) of cell suspension (35-50 mg cells/ml) were 
incubated as indicated in the presence of 1 mM 
theophylline for 3 min with or without hormone. 
The incubation was stopped with 500 ~1 of 15% 
cold trichloracetic acid. The supernatants were pu- 
rified on Dowex AG 50 W-X4 (200-400 mesh hy- 
drogen/vrm) as described in [ 191 @HIcAMP (8000 
cpm) was added to each sample in order to esti- 
mate the recovery of CAMP). 
All experiments, performed in triplicate, were 
repeated at least three times with different cell 
batches in order to ensure that the results were re- 
producible. All the data are presented as the 
meanf SD or SEM. Student’s test was used for 
statistical analysis. 
3. RESULTS 
The effects of GIP, secretin, VIP and glucagon 
on glucose and lactate production were first mea- 
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sured in liver cells from fed rats (tig.1). Neither 
GIP nor secretin affected these metabolic events. 
Many attempts to unmask a biological effect of 
these peptides were unsuccessful (data not shown). 
Only VIP and glucagon significantly affected both 
glucose and lactate production. The effects of VIP 
were additive with a submaximal dose of glucagon 
(fig.1) but not with the maximal effective dose of 
glucagon (data not shown). Fig.2 shows that the 
effect of VIP on glucose production was dose-de- 
pendent and the half maximum effect of the hor- 
mone occured at about 2.10-8 M. The inset shows 
that glucagon was more potent than VIP and acted 
at a much lower concentration (half maximum 
stimulation 3.10 -11 M). Fig.3 shows that the effect 
of VIP could be detected as soon as 3 min after 
hormone addition and persisted linearly for at 
least 20 min. In cells from 24 h-fasted rats, VIP in- 
creased gluconeogenesis from lactate or dihy- 
droxyacetone, but decreased it from 10 mM pyru- 
vate, as did glucagon (table 1). These effects were 
small but reproducible and statistically significant. 
This glucagon-like effect of VIP on glucose pro- 
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Fig. 1. Effects of glucagon and glucagon-related polypeptides on glucose and lactate production (X + SD, n = 3) in iso- 
lated liver cells from fed rats. Cells were incubated for 10 min as indicated in section 2 and glucose and lactate were 
measured in cell extract as indicated. *PC 0.0 1. 
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Table 1 
Effects of VIP (10 -’ M) and glucagon (10 -9 M) on gluconeogenesis 
Control 
VIP 10 -’ M 
Glut 10 -9 M 
* P<O.O5 
Lactate 10 mM 
13.020.1 
14.5 + 0.2* 
16.8+0.2* 
DHA 10 mM 
20.4kO.2 
22.8+0.1* 
27.2 + 0.3* 
Pyruvate 10 mM 
11.6kO.2 
10.9 *0.3* 
6.920.2’ 
Cells from 24 h-fasted rats were incubated for 20 min with 10 mM lactate, pyruvate or 
dihydroxyacetone. Glucose production was expressed as pmol/g of cells/20 min 
(X + SD, n=4) 
duction in cells from fed as well as fasted rats was phate, and phosphoenol pyruvate and decreased 
also substantiated by the measurement of some fructose- 1,6-diphosphate and pyruvate concentra- 
intermediary metabolites in cells from fed rats tions. This profile of the amounts of glycolytic in- 
incubated with 5 mM dihydroxyacetone (table 2). termediates uggests an effect of VIP at both the 
VIP addition, to a lesser extent than glucagon, Fru. 6 P=Fru. l-6 P and P-enolpyruvate= pyru- 
increased glucosed-phosphate, fructose-6-phos- vate steps. The hypothesis that VIP was actually 
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Fig.2. Dose-response curve of the glucose production induced by VIP and glucagon (inset). Cells from fed rats were 
incubated for 15 min as indicated in section 2 (X k SD, n = 6). 
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Table 2 
Effects of VIP (10-e M) and glucagon ( 10e9 M) on some intermediary metabolites 
ATP G6P F6P F-1,6-P DHAP PEP Pyruvate 
pmol/g nmol/g nmol/g nmol/g nmol/g nmol/g pmol/g 
Control 2.020.1 1262 13 51+8 39fl 181+ 18 138+ 10 5.420.2 
VIP 2.020.1 1762 13* 80+6* 3423 17424 1612 12* 4.5+0.1* 
Glucagon 2.0+0.1 370+27* 133+9* 26&5* 178? 12 201+22* 3.9+0.1* 
*p<o.o5 
Liver cells (50 mg/ml) from fed rats were incubated as indicated with 5 mM dihy- 
droxyacetone for 8 min with or without hormones (X f SEM, n = 3). 
Abbreviations: G6P, glucose-6-phosphate; F6P, fructose-6-phosphate; F- 1,6-P, fruc- 
tose-1,6_diphosphate; DHAP, dihydroxyacetone phosphate; PEP, phosphoenol 
pyruvate. 
Table 3 
Effects of VIP (10 -6 M) and glucagon (10 -9 M) on CAMP level and CAMP-dependent protein kinase activity. 
CAMP 
(nmol/g 
CAMP-dependent protein kinase CAMP-dependent protein kinase 
(U/mg protein) activity ratio - CAMP/ + CAMP 
- CAMP + CAMP (5 PM) 
Control 0.53 f 0.09 9658 3132 7 0.3 1 + 0.05 
VIP 10 -6 M 1.64 f 0.43 137+6 2942 11 0.47 2 0.02 
Glucagon 10 -9 M 14.6 20.6 216&8 2562 15 0.85 + 0.04 
CAMP was measured as indicated in purified trichloroacetic acid extracts from cells from fed rats incubated for 3 min 
with or without hormone. Protein kinase activity was measured as indicated within 30 min after homogeneizing the cell 
pellet. Liver cells (50 mg/ml) were incubated with or without hormone as indicated, for 8 min. Results are expressed as 
X 2 SEM of triplicate determination in 3 different cell batches (n = 3). 
acting at the P-enolpyruvate G= pyruvate step was 
tested by measuring the kinetics of L-pyruvate 
kinase, which catalyzes this metabolic event. The 
app. Ko.5 of P-enolpyruvate for L-pyruvate kinase 
was significantly increased by VIP (2.10-7 M) 
glucagon (10-g M) addition (Ko.5 PEP mM X + 
SD: control 0.40 + 0.02, n = 10; VIP 0.55 ? 0.02, 
n = 3; glucagon 0.82 f 0.05, n = 10). L-Pyruvate 
kinase has been shown to be regulated by a CAMP- 
dependent phosphorylation mechanism [ 11,201. 
ol Fig.3. Time course of VIP action on glucose production in cells from fed rats. Liver cells were incubated in 125 
10 
TIME 
20 
ml conical flask in the buffer indicated in section 2 and 
1 ml aliquots were sampled at the indicated time for 
glucose measurement (X f SD, n = 3). 
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Therefore the VIP-promoted inhibition of L-pyru- 
vate kinase strongly suggests that VIP acts by in- 
creasing CAMP levels. This hypothesis was tested 
by measuring both the CAMP level and the CAMP- 
dependent protein kinase activity ratio in extracts 
of liver cells incubated with and without hor- 
mones. Table 3 shows that VIP addition slightly in- 
creased the CAMP level, although the difference 
was not statistically significant. The reality of a 
slight rise in CAMP was confirmed by a significant 
increase in the CAMP-dependent protein kinase 
activity ratio which has been shown to be an accur- 
ate stimulation of small changes in CAMP level 
[15]. The effect of glucagon on both parameters 
was much more pronounced. 
4. DISCUSSION 
The present report clearly confirms that glucose 
and lactate metabolism are strongly modified by 
VIP but not by GIP and secretin which also belong 
to the glucagon polypeptide family [9]. The stim- 
ulation of glucose production in cells from fed rats 
was dose- and time-dependent (figs. 2,3). It can be 
related to the stimulation of glycogenolysis since 
VIP activates phosphorylase activity in rat liver 
cells [4]. The inhibition of lactate production (tig.1) 
induced by VIP can be related, at least in part, to 
an inhibition of L-pyruvate kinase. Effectively, the 
enzyme activity was decreased by VIP when mea- 
sured at physiological substrate concentration 
while lactate and pyruvate concentrations were re- 
duced and phosphoenolpyruvate increased by VIP 
addition (table 2). VIP also affects glucose metabo- 
lism in cells from 24 h-fasted rats. Although small 
(table 1) the effect was reproducible and similar 
but smaller to the effect of glucagon. The relatively 
small effect of both peptides on gluconeogenesis 
not comparable to data in the literature using iso- 
topic tracer methods [21] but is similar to what has 
been reported on the effect of glucagon on gluco- 
neogenesis from unlabelled lactate and DHA [22]. 
The inhibition of gluconeogenesis from 10 mM 
pyruvate by glucagon (table 1) has already been 
reported [23,24]. 
All these biochemical effects are probably re- 
lated, at least partially, to a CAMP-dependent 
mechanism, since VIP increases the CAMP level 
and the CAMP-dependent protein kinase activity 
(table 3) and since both phosphorylase and pyru- 
vate kinase activities are modulated by a CAMP- 
dependent phosphorylation [20]. 
All the effects of VIP, so far tested, were similar 
to the effects of glucagon but the magnitude of the 
effects were smaller and the sensitivity to the pep- 
tide was lower, at least when tested on glucose pro- 
duction Similar results have been obtained when 
tested on glycogen metabolism [4]. The small am- 
plitude of the VIP effect compared to glucagon 
may be related to a smaller activation of adenylate 
cyclase since in isolated membrane preparation the 
activation of adenylate cyclase was also small 
[5-81. These data tend to support the hypothesis 
that VIP acts through the glucagon receptor to 
which it would bind with a lower affinity constant. 
In fact this hypothesis seems very unlikely since 
VIP and glucagon have separate binding sites in 
liver [5,8] and since their maximal effects on mem- 
brane adenylate cyclase were additive [5]. Sur- 
prisingly, the relatively low sensitivity of liver cells 
to VIP (2.10-s M) did not correlate with the high 
affinity of VIP for its receptor which has been 
shown to be in the lo-to molar range [8]. These 
discrepancies have been tentatively related to a 
poor coupling of the VIP receptor to the N2 GTP 
binding protein of the adenylate cyclase system 
[25]. Further studies are needed to elucidate these 
discrepancies. 
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